Press Releases

Date Title and Summary View
Toggle Summary Macroflux Names M. Cory Zwerling President, CEO
Macroflux Names M. Cory Zwerling President, CEO Macroflux, an emerging specialty pharmaceutical company focused on the development of proprietary products, has named M. Cory Zwerling President and CEO of the company. “This is an exciting opportunity to lead Macroflux with a strong team,
View HTML
Toggle Summary Launch of Macroflux Corporation
Launch of Macroflux Corporation Macroflux Corporation has raised $75 million in an equity financing to create a new transdermal drug development company.
View HTML